SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-025347
Filing Date
2023-02-24
Accepted
2023-02-24 16:46:09
Documents
12
Period of Report
2023-02-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm237799d1_8k.htm   iXBRL 8-K 24224
  Complete submission text file 0001104659-23-025347.txt   199822

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA aplt-20230217.xsd EX-101.SCH 3066
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE aplt-20230217_lab.xml EX-101.LAB 34476
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aplt-20230217_pre.xml EX-101.PRE 22617
6 EXTRACTED XBRL INSTANCE DOCUMENT tm237799d1_8k_htm.xml XML 3688
Mailing Address 545 5TH AVENUE, SUITE 1400 NEW YORK NY 10017
Business Address 545 5TH AVENUE, SUITE 1400 NEW YORK NY 10017 212-220-9319
Applied Therapeutics Inc. (Filer) CIK: 0001697532 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38898 | Film No.: 23668148
SIC: 2834 Pharmaceutical Preparations